To treat COVID-19 patients, US Food and Drug Administration gave Eli Lilly an emergency use approval for baricitinib in combination with remdesivir last year
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.